Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells

被引：0
|
作者：
Kurihara, E. [1 ]
Shien, K. [1 ]
Torigoe, H. [1 ]
Takahashi, Y. [1 ]
Ogoshi, Y. [1 ]
Yoshioka, T. [1 ]
Namba, K. [1 ]
Sato, H. [1 ]
Yamamoto, H. [1 ]
Soh, J. [1 ]
Toyooka, S. [1 ]
机构：
[1] Okayama Univ, Gen Thorac Surg & Breast & Endocrinol Surg, Okayama, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
HSP90; inhibitor; drug resistance;
D O I：
10.1016/j.jtho.2018.08.870
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.13-13
引用
收藏
页码：S586 / S587
页数：2
相关论文
共 40 条
  • [1] EGFR-TKI resistance in NSCLC patients: mechanisms and strategies
    Lin, Yuxin
    Wang, Xian
    Jin, Hongchuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (05): : 411 - 435
  • [2] Transglutaminase 2 induces intrinsic EGFR-TKI resistance in NSCLC harboring EGFR sensitive mutations
    Choi, Junyoung
    Yoon, Shinkyo
    Kim, Deokhoon
    Moon, Yong Wha
    Lee, Chang Hoon
    Seo, Seyoung
    Cheon, Jaekyung
    Gho, Yong Song
    Kim, Changhoon
    Lee, Eung Ryoung
    Kim, Soo-Youl
    Lee, Kyoungmin
    Ha, Joo Young
    Park, Sook Ryun
    Kim, Sang-We
    Park, Kang-Seo
    Lee, Dae Ho
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (08): : 1708 - +
  • [3] Acquired Resistance Mechanisms to Combination Met-TKI/EGFR-TKI Exposure in Met-Amplified EGFR-TKI-Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
    Yamaoka, Toshimitsu
    Ohmori, Tohru
    Ohba, Motoi
    Arata, Satoru
    Kishino, Yasunari
    Murata, Yasunori
    Kusumoto, Sojiro
    Ishida, Hiroo
    Shirai, Takao
    Hirose, Takashi
    Ohnishi, Tsukasa
    Sasaki, Yasutsuna
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (12) : 3040 - 3054
  • [4] A NOVEL CRM1 INHIBITOR TARGETING FOR NSCLC WITH EGFR-TKI RESISTANCE MUTATION
    Wang, Shuai
    Han, Xiaohong
    Shi, Yuankai
    Wang, Michael
    Zhang, Liang
    Mccauley, Dilara
    Kauffman, Michael Kauffman
    Shacham, Sharon Shacham
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S774 - S774
  • [5] Analysis of the lncRNA-miRNA-mRNA Network Reveals a Potential Regulatory Mechanism of EGFR-TKI Resistance in NSCLC
    Ding, Dandan
    Zhang, Jufeng
    Luo, Zhiming
    Wu, Huazhen
    Lin, Zexiao
    Liang, Weicheng
    Xue, Xingyang
    FRONTIERS IN GENETICS, 2022, 13
  • [6] Cigarette smoke extract induces EGFR-TKI resistance via promoting EGFR signaling pathway and ROS generation in NSCLC cell lines
    Zhang, Lu
    Li, Jun
    Hu, Jing
    Li, Dandan
    Wang, Xiaohui
    Zhang, Rui
    Zhang, Hui
    Shi, Meng
    Chen, Hong
    LUNG CANCER, 2017, 109 : 109 - 116
  • [7] Diverse Mechanisms of Resistance against Osimertinib, a Third-Generation EGFR-TKI, in Lung Adenocarcinoma Cells with an EGFR-Activating Mutation
    Nishihara, Shigetoshi
    Yamaoka, Toshimitsu
    Ishikawa, Fumihiro
    Ohmori, Tohru
    Ando, Koichi
    Kusumoto, Sojiro
    Kishino, Yasunari
    Manabe, Ryo
    Hasebe, Yuki
    Sagara, Hironori
    Yoshida, Hitoshi
    Tsurutani, Junji
    CELLS, 2022, 11 (14)
  • [8] The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC
    Wang, Zhi
    Zhang, Lingling
    Xu, Wenwen
    Li, Jie
    Liu, Yi
    Zeng, Xiaozhu
    Zhong, Maoxi
    Zhu, Yuxi
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 649 - 667
  • [9] Anti-tumor effects of an ID antagonist with no observed acquired resistance
    Wojnarowicz, Paulina M.
    Escolano, Marta Garcia
    Huang, Yun-Han
    Desai, Bina
    Chin, Yvette
    Shah, Riddhi
    Xu, Sijia
    Yadav, Saurabh
    Yaklichkin, Sergey
    Ouerfelli, Ouathek
    Soni, Rajesh Kumar
    Philip, John
    Montrose, David C.
    Healey, John H.
    Rajasekhar, Vinagolu K.
    Garland, William A.
    Ratiu, Jeremy
    Zhuang, Yuan
    Norton, Larry
    Rosen, Neal
    Hendrickson, Ronald C.
    Zhou, Xi Kathy
    Iavarone, Antonio
    Massague, Joan
    Dannenberg, Andrew J.
    Lasorella, Anna
    Benezra, Robert
    NPJ BREAST CANCER, 2021, 7 (01)
  • [10] Protein tyrosine kinase 2: a novel therapeutic target to overcome acquired EGFR-TKI resistance in non-small cell lung cancer
    Tong, Xuexia
    Tanino, Ryosuke
    Sun, Rong
    Tsubata, Yukari
    Okimoto, Tamio
    Takechi, Mayumi
    Isobe, Takeshi
    RESPIRATORY RESEARCH, 2019, 20 (01)
1234